Month: December 2024

Zahrawi Group, in partnership with Medtronic, participated in the Robotic Surgery Collaboration Summit 2024 held at Cleveland Clinic Abu Dhabi. This event brought together leading experts and institutions to explore the latest advancements in robotic surgery, focusing on areas such as abdominal wall reconstruction, bariatric surgery, colorectal and gastrointestinal procedures, emergency surgery, hepato-pancreato-biliary techniques, and digital surgery.

The summit provided a platform for sharing knowledge through panel discussions, interactive presentations, and case studies. In addition to clinical advancements, it addressed topics like leadership, entrepreneurship, and innovation in the surgical field, aiming to equip participants with the tools to advance robotic surgery and foster mentorship across the region.

Zahrawi Group’s Surgical team showcased Medtronic’s Hugo™ RAS Platform, Covidien Signia™ stapling devices, and Covidien Sonicision™ at the event. The Hugo™ RAS Platform is a next-generation system designed to enhance precision and flexibility in minimally invasive procedures. The Covidien Signia™ staplers provide adaptive feedback and precision for a range of surgical needs, while the Covidien Sonicision™ cordless ultrasonic dissection tool improves efficiency and precision during surgeries.

These demonstrations reflected Zahrawi Group’s commitment to advancing surgical technology in the region and improving patient outcomes. Our partnership with Medtronic continues to play a vital role in bringing innovative solutions to healthcare providers and supporting the development of advanced surgical practices.

We are thrilled to announce the first launch of SIROS™-Sirtex’s innovative New Dose Administration System in Oman. This milestone was achieved in collaboration with our esteemed client, Sultan Qaboos Comprehensive Cancer Care and Research Center (SQCCCRC-UMC) in Muscat, under the visionary leadership of Dr. Rashid Al Sukaiti. Notably, SQCCCRC has become the first public hospital in the GCC region to implement this cutting-edge system for the delivery of Y-90 therapy, marking a significant advancement in cancer care.

The SIROS™ Delivery System offers an intuitive, visual, and adaptable solution for physicians to administer SIR-Spheres to liver cancer patients. Its easy-to-use design along with the controlled administration provides the physicians confidence in the Y-90 delivery.

We would like to extend our heartfelt gratitude to Dr. Rashid Al Sukaiti, Dr. Khulood Al Riyami and their dedicated teams, our Sales team and our partner Sirtex for their tireless efforts in making this project a reality. Together, we are committed to advancing healthcare technology for a brighter future!

Key features of SIROS system include:

• Visual: Visually controlled administration enables precision.
• Intuitive: Intuitive design for easy set-up, fluid administration and quick disposal.
• Versatility: Enhanced control allows for more options to tailor sphere delivery.

At Zahrawi Group, we believe in harnessing advanced technology to advance the field of oncology and provide the best possible solutions to our healthcare partners. This launch represents our commitment to supporting patients and practitioners in the journey towards better health.

Our commitment to improving patient care drives us to continually push the boundaries of medical technology. We believe this new system will revolutionize the way liver radioembolization is performed, ultimately leading to better patient outcomes.